000 | 01019 a2200313 4500 | ||
---|---|---|---|
005 | 20250514020652.0 | ||
264 | 0 | _c20021010 | |
008 | 200210s 0 0 eng d | ||
022 | _a0277-6715 | ||
024 | 7 |
_a10.1002/sim.1018 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aWillan, A R | |
245 | 0 | 0 |
_aCost-effectiveness analysis when the WTA is greater than the WTP. _h[electronic resource] |
260 |
_bStatistics in medicine _cNov 2001 |
||
300 |
_a3251-9 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aBayes Theorem |
650 | 0 | 4 | _aBiometry |
650 | 0 | 4 |
_aClinical Trials as Topic _xeconomics |
650 | 0 | 4 | _aCost-Benefit Analysis |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aPalliative Care _xeconomics |
650 | 0 | 4 |
_aProstatic Neoplasms _xdrug therapy |
700 | 1 | _aO'Brien, B J | |
700 | 1 | _aLeyva, R A | |
773 | 0 |
_tStatistics in medicine _gvol. 20 _gno. 21 _gp. 3251-9 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1002/sim.1018 _zAvailable from publisher's website |
999 |
_c11659285 _d11659285 |